Peter Morgan Kash

Dr. Peter M.
Kash is an Independent Director at Healthcare Capital Corp.
(Delaware), a Managing Director at FFD, Inc., a Vice Chairman at Targimmune Therapeutics AG, a Chairman & President at Riverbank Capital Securities, Inc. and a President at Two River Group Management LLC.
He is on the Board of Directors at Healthcare Capital Corp.
(Delaware), Targimmune Therapeutics AG, Cancer Schmancer Foundation, Danube Pharmaceuticals, Inc., Fran Dreschers Organization, Keren Or, Inc. and Kirax Corp.
Dr. Kash was previously employed as a Non-Executive Director by Firebrick Pharma Ltd., a Partner by Two River Group Holdings LLC, an Adjunct Professor by University of Pennsylvania, a Senior Managing Director by Paramount BioCapital, Inc., a Co-Founder by Andorra International, Inc., an Independent Director by Nile Therapeutics, Inc., a Vice Chairman by Javelin Pharmaceuticals, Inc., a Vice Chairman by Keryx Biopharmaceuticals, Inc., a Vice Chairman by NAYA Biosciences, Inc., a General Partner by Orion Biomedical Fund LP, a Co-Founder by PolaRx Biopharmaceuticals, an Associate Professor-Marketing by Polytechnic University, and a Vice Chairman by Velcera Pharmaceuticals, Inc. /Old/.
He also served on the board at LabStyle Innovations Corp., Arno Therapeutics, Inc., Arno Therapeutics, Inc. /Old/, ID Vaccine Corp., Intercept Pharmaceuticals, Inc., Nile Therapeutics, Inc. /Old/ and Paramount BioCapital Asset Management, Inc. He received his undergraduate degree from State University of New York at Binghamton, an MBA from Lubin School of Business and a doctorate degree from Yeshiva University.